LifeArc

London, England, United Kingdom

Overview

LifeArc is the new name for MRC Technology, a medical research charity with a 25 year legacy of helping scientists and organisations turn their research into treatments and diagnostics for patients. \The new name reflects our purpose: to be the arc or bridge between research and improving patients' lives.\\LifeArc is pioneering new ways to turn great science into greater patient impact. We bring together a network of partners to tackle specific diseases and directly fund academic and early stage research. \\We have a London office and dedicated laboratories in Stevenage, where around 80 scientists work on antibody and small molecule projects, while the Edinburgh lab progresses diagnostics development. \\So far, our work has helped to develop four drugs (Keytruda®, Actemra®, Tysabri® and Entyvio®) and a test for antibiotic resistance. \\www.lifearc.org Twitter @lifearc1.\

Get the full list of 54,000+ investors

LifeArc and every other firm and angel in the database — as one spreadsheet you keep.

$19one-time payment · no subscription
  • All 54,000+ investors — VC firms, private equity, family offices and angels
  • The key person to contact at each one, with their job title
  • Their work email address
  • Their phone number
  • Their LinkedIn profile
  • Delivered as a single .xlsx file — download it as many times as you like
Get the full list — $19 → One payment. No seats, no credits, no expiry. Already bought it? Sign in to download it again — no second payment.

Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.

Frequently asked questions about LifeArc

Who are the partners at LifeArc?

Team members listed for LifeArc include Adrien Lemoine (Chief Business Officer) and Fiona Roberts (Chief People Officer).

How do I contact LifeArc?

LifeArc's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.

Last updated · Source: ConnectSafely investor database